Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.
Saved in:
| Title: | Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. |
|---|---|
| Authors: | Meraz IM; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. imeraz@mdanderson.org., Majidi M; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fang B; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meng F; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gao L; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shao R; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Song R; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li F; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lissanu Y; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chen H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ha MJ; Department of Biostatistics, Graduate School of Public Health, Yonsei University, Seoul, Korea., Wang Q; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shpall E; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jung SY; Department of Biochemistry, Baylor College of Medicine, Houston, TX, USA., Haderk F; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Gui P; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Riess JW; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Olivas V; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Bivona TG; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Roth JA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
| Source: | Communications biology [Commun Biol] 2023 Jun 06; Vol. 6 (1), pp. 608. Date of Electronic Publication: 2023 Jun 06. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37280434 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Meraz+IM%22">Meraz IM</searchLink>; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. imeraz@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Majidi+M%22">Majidi M</searchLink>; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Fang+B%22">Fang B</searchLink>; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Meng+F%22">Meng F</searchLink>; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Gao+L%22">Gao L</searchLink>; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Shao+R%22">Shao R</searchLink>; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Song+R%22">Song R</searchLink>; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Li+F%22">Li F</searchLink>; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lissanu+Y%22">Lissanu Y</searchLink>; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ha+MJ%22">Ha MJ</searchLink>; Department of Biostatistics, Graduate School of Public Health, Yonsei University, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Wang+Q%22">Wang Q</searchLink>; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Shpall+E%22">Shpall E</searchLink>; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Jung+SY%22">Jung SY</searchLink>; Department of Biochemistry, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Haderk+F%22">Haderk F</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gui+P%22">Gui P</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Riess+JW%22">Riess JW</searchLink>; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.<br /><searchLink fieldCode="AU" term="%22Olivas+V%22">Olivas V</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bivona+TG%22">Bivona TG</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Roth+JA%22">Roth JA</searchLink>; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101719179%22">Communications biology</searchLink> [Commun Biol] 2023 Jun 06; Vol. 6 (1), pp. 608. <i>Date of Electronic Publication: </i>2023 Jun 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+UK%22">Nature Publishing Group UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101719179 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2399-3642 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223993642%22">23993642 </searchLink><i>NLM ISO Abbreviation: </i>Commun Biol <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37280434 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s42003-023-04979-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 608 Titles: – TitleFull: Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Meraz IM – PersonEntity: Name: NameFull: Majidi M – PersonEntity: Name: NameFull: Fang B – PersonEntity: Name: NameFull: Meng F – PersonEntity: Name: NameFull: Gao L – PersonEntity: Name: NameFull: Shao R – PersonEntity: Name: NameFull: Song R – PersonEntity: Name: NameFull: Li F – PersonEntity: Name: NameFull: Lissanu Y – PersonEntity: Name: NameFull: Chen H – PersonEntity: Name: NameFull: Ha MJ – PersonEntity: Name: NameFull: Wang Q – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Shpall E – PersonEntity: Name: NameFull: Jung SY – PersonEntity: Name: NameFull: Haderk F – PersonEntity: Name: NameFull: Gui P – PersonEntity: Name: NameFull: Riess JW – PersonEntity: Name: NameFull: Olivas V – PersonEntity: Name: NameFull: Bivona TG – PersonEntity: Name: NameFull: Roth JA IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 06 Text: 2023 Jun 06 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2399-3642 Numbering: – Type: volume Value: 6 – Type: issue Value: 1 Titles: – TitleFull: Communications biology Type: main |
| ResultId | 1 |